Understanding the Role of the Immune System in Improving Tissue Regeneration Proceedings of a Workshop (2022) / Chapter Skim
Currently Skimming:
References
References
Pages 127-140
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 127... ...
1998. Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose.
|
From page 128... ...
Stem Cells Translational Medicine 9(10)
|
From page 129... ...
2021b. Hypoim mune induced pluripotent stem cell-derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice.
|
From page 130... ...
2019a. Tissue immune profiles supporting response to mes enchymal stromal cell therapy in acute graft-versus-host disease-a gut feeling.
|
From page 131... ...
2017. Membrane particles generated from mesenchy mal stromal cells modulate immune responses by selective targeting of pro-inflammatory monocytes.
|
From page 132... ...
2018. Chromatin accessibility identifies diversity in mesenchymal stem cells from different tissue origins.
|
From page 133... ...
2016. Cardiomyocytes derived from MHC-homozygous induced pluripo tent stem cells exhibit reduced allogeneic immunogenicity in MHC-matched non-human primates.
|
From page 134... ...
2010. Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance.
|
From page 135... ...
2011. Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses.
|
From page 136... ...
1987. Infectious complications in patients undergoing marrow transplantation: A prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics.
|
From page 137... ...
2019. Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells.
|
From page 138... ...
2013. Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy.
|
From page 139... ...
2020. Pluripotent stem cell–derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.